First Time Loading...

Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 336 JPY -5.35% Market Closed
Updated: May 17, 2024

Sumitomo Pharma Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sumitomo Pharma Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Income from Continuing Operations
-¥181.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Income from Continuing Operations
¥144.2B
CAGR 3-Years
-27%
CAGR 5-Years
1%
CAGR 10-Years
3%
Daiichi Sankyo Co Ltd
TSE:4568
Income from Continuing Operations
¥201B
CAGR 3-Years
39%
CAGR 5-Years
16%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Income from Continuing Operations
¥141.7B
CAGR 3-Years
-4%
CAGR 5-Years
11%
CAGR 10-Years
-1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Income from Continuing Operations
¥326.4B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
18%
Astellas Pharma Inc
TSE:4503
Income from Continuing Operations
¥17B
CAGR 3-Years
-48%
CAGR 5-Years
-40%
CAGR 10-Years
-15%

See Also

What is Sumitomo Pharma Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-181.8B JPY

Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Income from Continuing Operations amounts to -181.8B JPY.

What is Sumitomo Pharma Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-568%

Over the last year, the Income from Continuing Operations growth was -568%.